TrialNet : a network of clinical centers, investigators,
and core support facilities in the U.S. and Canada that supports the development
and implementation of clinical trials of agents to slow the progression of type
1 diabetes in new-onset patients and to prevent type 1 diabetes in those at-risk
of developing the disease.
Immune Tolerance Network : an international consortium that evaluates
promising tolerogenic treatment regimens in four clinical areas: islet transplantation,
kidney transplantation, autoimmune diseases, and asthma and allergy diseases.
General Inquiries may be addressed to: Office of Communications and Public Liaison NIDDK, NIH Building 31, Rm 9A06 31 Center Drive, MSC 2560 Bethesda, MD 20892-2560 USA For information about NIDDK programs: 301.496.3583